Asma Rehman is an emerging chemist and researcher from the University of Agriculture, Faisalabad, Pakistan, with a strong academic foundation in green and sustainable chemistry. She earned her Bachelor’s degree in Chemistry from Government College University, Faisalabad, and completed her M.Phil. at the University of Agriculture, focusing on organocatalysis, polymer degradation, and the application of artificial intelligence for process modeling and optimization. Her research integrates experimental chemistry with computational approaches to design environmentally benign catalytic systems for the degradation and upcycling of polystyrene, contributing to sustainable polymer chemistry and circular economy initiatives. Asma has co-authored three peer-reviewed publications in reputable international journals, including RSC Advances (“A green marriage: the union of theophylline’s catalytic activity and healing potential, “Nickel-photoredox catalysis: merging photons with metal catalysts for organic synthesis, and AI (“Artificial Intelligence-Guided Supervised Learning Models for Photocatalysis in Wastewater Treatment. Her interdisciplinary expertise bridges chemistry and artificial intelligence, enabling innovative, data-driven insights into sustainable materials and environmental remediation. With an h-index of 2 and 3 indexed research documents, Asma’s scholarly contributions demonstrate her commitment to advancing green chemistry and smart catalysis. Her ongoing research aims to develop scalable catalytic processes that align with the United Nations Sustainable Development Goals, emphasizing responsible production, clean technologies, and climate action for a more sustainable future.

Dr. David M. Karnak, Ph.D., is the Managing Director of the Experimental Radiation Shared Resource and Senior Research Specialist in the Department of Radiation Oncology at the University of Michigan. He earned his B.S. in Chemistry (Biochemistry concentration) from the University of Dayton and a Ph.D. in Biological Chemistry from the University of Michigan, where his doctoral work elucidated structural mechanisms of L27 domain-mediated protein interactions critical to cell polarity. Over his two-decade research career, Dr. Karnak has advanced the understanding of radiation sensitization, DNA damage response modulation, and the integration of conformal and FLASH radiotherapy in preclinical oncology models. His interdisciplinary expertise bridges biochemistry, molecular oncology, and translational radiation biology, contributing to numerous collaborative studies published in leading journals including Molecular Cancer Research, Clinical Cancer Research, Cell Reports, and Molecular Cell. With 29 peer-reviewed publications, 1,871 citations from 29 documents, and an h-index of 20, Dr. Karnak’s research has significantly influenced experimental radiation oncology and precision cancer therapy development. Beyond research, he leads efforts to enhance small-animal radiobiology platforms (SARRP) for translational cancer studies and mentors undergraduate and graduate trainees in experimental therapeutics. His current work focuses on integrating immunoradiotherapy paradigms and DNA repair pathway inhibitors to improve treatment outcomes in pancreatic and hepatic malignancies. Dr. Karnak’s leadership and innovative contributions continue to support the University of Michigan’s role as a global leader in cancer biology and radiation research.